Skip to results
Modify your search
NARROW
1-8 of 8
Keywords: bromocriptine
Sort by
Journal Article
Bromocriptine treatment and outcomes in peripartum cardiomyopathy: the EORP PPCM registry
Peter van der Meer and others
European Heart Journal, Volume 46, Issue 11, 14 March 2025, Pages 1017–1027, https://doi.org/10.1093/eurheartj/ehae559
Published: 02 September 2024
..., and reproduction in any medium, provided the original work is properly cited. Abstract Background and Aims Peripartum cardiomyopathy (PPCM) remains a serious threat to maternal health around the world. While bromocriptine, in addition to standard treatment for heart failure, presents a promising pathophysiology...
Journal Article
Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy
Get access
Jan-Thorben Sieweke and others
European Heart Journal. Acute Cardiovascular Care, Volume 9, Issue 2, 1 March 2020, Pages 173–182, https://doi.org/10.1177/2048872618777876
Published: 01 March 2020
... inhibitor bromocriptine in refractory cardiogenic shock complicating peripartum cardiomyopathy. Methods and results In this single-centre analysis, five peripartum cardiomyopathy patients with refractory cardiogenic shock received mechanical circulatory support with either Impella CP microaxial pump...
Journal Article
EDITOR'S CHOICE
Peripartum cardiomyopathy: basic mechanisms and hope for new therapies
Get access
Melanie Ricke-Hoch and others
Cardiovascular Research, Volume 116, Issue 3, 1 March 2020, Pages 520–531, https://doi.org/10.1093/cvr/cvz252
Published: 12 October 2019
... failure Bromocriptine Historically, in Western societies PPCM had been considered a rare disease and seemed to affect mainly African women or women of African ancestry. However, in line with other forms of cardiovascular disease, the incidence of PPCM is steadily on the rise in Western countries being...
Journal Article
EDITOR'S CHOICE
FAST TRACK
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study
Denise Hilfiker-Kleiner and others
European Heart Journal, Volume 38, Issue 35, 14 September 2017, Pages 2671–2679, https://doi.org/10.1093/eurheartj/ehx355
Published: 27 July 2017
... depicting inducers of increased oxidative stress in the peripartum maternal heart that mediate the generation of antiangiogenic 16kDa prolactin from the nursing hormone prolactin which drives PPCM as well as the hypothetic mechanisms how the prolactin release blocker bromocriptine together with standard...
Journal Article
Current knowledge and recent development on management of peripartum cardiomyopathy
Get access
Nadia Bouabdallaoui and others
European Heart Journal. Acute Cardiovascular Care, Volume 6, Issue 4, 1 June 2017, Pages 359–366, https://doi.org/10.1177/2048872615612465
Published: 01 June 2017
...Nadia Bouabdallaoui; Frederic Mouquet; Guillaume Lebreton; Pierre Demondion; Thierry H Le Jemtel; Pierre V Ennezat Peripartum cardiomyopathy heart failure bromocriptine left ventricular assist device heart transplantation Peripartum cardiomyopathy (PPCM) refers to the development of heart...
Journal Article
Central dopaminergic origin of bromocriptine induced tachycardia in normotensive rats
Get access
Saad Lahlou and others
Cardiovascular Research, Volume 27, Issue 11, November 1993, Pages 2022–2027, https://doi.org/10.1093/cvr/27.11.2022
Published: 01 November 1993
...Saad Lahlou; Gloria Pinto Duarte; Pierre Demenge Correspondence to Dr Demenge. We are greatly indebted to the CNRS (URA 1287) and the Université Joseph Fourier for their financial support. We also thank Sandoz Pharmaceuticals and Janssen Pharmaceuticals for their generous gifts of bromocriptine...
Chapter
Peripartum cardiomyopathy
Get access
Karen Sliwa and Denise Hilfiker-Kleiner
Published: 01 July 2018
Updated: 28 November 2019
... guidelines for the management of cardiovascular diseases during pregnancy included treatment with bromocriptine in management recommendations of patients with PPCM (class IIb recommendation). Clinical trial and registries reporting on disease-specific therapies, that is, the use of prolactin blockers...
Chapter
Cardiomyopathies and heart failure in pregnancy
Get access
Vera Regitz-Zagrosek
Published: 01 July 2018
Updated: 30 July 2020
... cardiomyopathy heart failure treatment bromocriptine cardiomyopathies heart disease in pregnancy heart failure HF hypertrophic cardiomyopathy HCM gestational hypertension hypertension preeclampsia This chapter provides the background information and detailed discussion of the data for the following...